BRANDON VAN DEMAN: Open Payments
NPI 1629693841 · LINDALE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 25 payments from 13 companies in 2025. Trend: 2023 $272 · 2024 $493 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $76 |
| Corcept Therapeutics | 2 | $71 |
| Novo Nordisk Inc | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $44 |
| Exact Sciences Corporation | 2 | $38 |
| Amgen Inc. | 2 | $28 |
| Lilly USA, LLC | 2 | $28 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Dynavax Technologies Corporation | 1 | $18 |
Products named: TRELEGY ELLIPTA, Korlym, JARDIANCE, Ozempic, MOUNJARO, Rybelsus, ZORYVE, REXULTI.
Industry payments across TX — which companies pay providers there.
